Todas notícias "GLP-1 agonists"
-
Últimas Notícias
Pop star Lexa reveals severe hair loss after Mounjaro use, sparks new health warnings for 2025
Pop star Lexa reveals severe hair loss after Mounjaro use, sparks new health warnings for 2025 Brazilian singer Lexa, 30, has openly...
-
News (UR)GLP-1 منشیات کی نئی لہر موجودہ علاج سے دوگنا وزن میں کمی کا وعدہ کرتی ہے
دواسازی کی کمپنیاں GLP-1 رسیپٹر ایگونسٹس کے نئے ورژن تیار کررہی ہیں جو ایک سے زیادہ آنتوں کے ہارمونز پر کام کرتی...
-
News (HA)
Sabbin magungunan GLP-1 sunyi alkawarin asarar nauyi har sau biyu fiye da jiyya na yanzu
Kamfanonin harhada magunguna suna haɓaka sabbin nau’ikan agonists masu karɓa na GLP-1 waɗanda ke aiki akan hormones na hanji da yawa kuma...
-
News (PH)
Ang bagong wave ng mga gamot na GLP-1 ay nangangako ng pagbaba ng timbang ng hanggang dalawang beses kaysa sa mga kasalukuyang paggamot
Gumagawa ang mga kumpanya ng parmasyutiko ng mga bagong bersyon ng GLP-1 receptor agonists na kumikilos sa maraming intestinal hormones at maaaring...
-
News (EN)
New wave of GLP-1 drugs promises weight loss up to twice as much as current treatments
Pharmaceutical companies are developing new versions of GLP-1 receptor agonists that act on multiple intestinal hormones and can cause significantly greater reductions...
-
Últimas NotíciasSustaining weight loss post-jabs: experts reveal challenges and strategies for long-term health management
Many individuals achieve significant weight reduction using popular GLP-1 agonist medications, often referred to as weight-loss jabs, reaching their desired goals. However,...
-
57EUAOzempic sparks alerts: misuse rises and heightens risks of eating disorders
The rapid rise in popularity of medications like Ozempic, originally developed to treat type 2 diabetes, has sparked growing concerns among mental...